Hayes Wong,Sazzad Hossain,Brian Cairns,Alexandra Mancini
申请号：
US16649119
公开号：
US20200289458A1
申请日:
2018.09.21
申请国别(地区):
US
年份:
2020
代理人:
摘要：
Pharmaceutical compositions comprising one or more cannabinoids and a pharmaceutically acceptable carrier are disclosed. The compositions are in a form suitable for topical administration, and are useful in the treatment of pain. The cannabinoids suitable for use include cannabidiols, cannabinols, and various other naturally occurring and synthetic cannabinoids. The compositions may also further include anti-inflammatory agents, steroids, or terpenoids. In preferred embodiments, the cannabinoids incorporated in the compositions are cannabidiol (CBD) and cannabinol (CBN) while the carriers are selected from the group consisting of Labrasol™；, Transcutol™；, lecithin, lysolecithin, isopropyl palmitate, and isopropyl myristate.
